NCT02472353 Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer Status TERMINATED Phase PHASE2
NCT02463357 Three New Ideas to Protect Special Forces From the Stress of High Altitude Status COMPLETED Phase PHASE4
NCT02457286 Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study Status WITHDRAWN Phase PHASE1
NCT02446834 Research of Intensive Lifestyle Intervention for PCOS Patients With IGT Status COMPLETED Phase NA
NCT02443922 Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM Status UNKNOWN Phase NA
NCT02438540 Comparative the Effect of Metformin and Acupuncture on Weight Loss and Insulin Sensitivity Status COMPLETED Phase NA
NCT02438397 the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin Status UNKNOWN Phase PHASE4
NCT02438020 Study of Efficacy of Metformin in the Treatment of Acanthosis Nigricans in Children With Obesity Status UNKNOWN Phase PHASE4
NCT02437812 Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma Status UNKNOWN Phase PHASE2
NCT02437656 Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer. Status COMPLETED Phase PHASE2
NCT02435277 An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients Status COMPLETED Phase PHASE2
NCT02434744 Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02429258 Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin Status COMPLETED Phase PHASE4
NCT02417090 Late Metabolic Effects of Metformin Therapy in Gestational Diabetes Status COMPLETED Phase N/A
NCT02411825 Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients Status COMPLETED Phase PHASE1
NCT02409238 Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study Status TERMINATED Phase PHASE4